Uncategorized

Regeneron-backed City builds RNAi pipeline with $99.5M series B

Regeneron-backed City builds RNAi pipeline with $99.5M series B

Published

3 days ago

on

June 8, 2026

By

Temp User

City Therapeutics, one of BioSpace’s NextGen companies for 2026, is helmed by RNA royalty John Maraganore, former CEO of Alnylam. Read More

Related Topics:

Leave a Reply

Uncategorized9 years ago

These ’90s fashion trends are making a comeback in 2017
Uncategorized9 years ago

According to Dior Couture, this taboo fashion accessory is back
Endpoints News3 months ago

Novartis to pay $2B upfront to take next-gen PI3Kα inhibitor from Synnovation
Uncategorized9 years ago

Phillies’ Aaron Altherr makes mind-boggling barehanded play
Uncategorized9 years ago

Uber and Lyft are finally available in all of New York State
Contributors9 years ago

The final 6 ‘Game of Thrones’ episodes might feel like a full season

Exit mobile version